Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03034278 · ClinicalTrials.gov registry record
Self-reported Usage Patterns of Opioid Analgesic Medications After Surgery
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 785
- Enrollment target
NCT03034278: Completed study, sponsored by University of Colorado, Denver.
NCT03034278 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 785 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03034278 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 785 participants
- Enrollment target
Study Summary
The primary objective of this study is to better understand post-discharge utilization of prescribed opioid analgesic medications following surgery. A secondary objective of this study is to gain a better understanding of prevailing modes of storage for opioid medications.
Primary Outcome
A self-report survey will assess opioid medication use in surgical patients during the 4 weeks following hospital discharge.
Interventions
- OTHER Not applicable - no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 785 participants |
| Start Date | 2017-02-03 |
| Est. Completion | 2021-07-31 |
What the finished NCT03034278 record still lists
NCT03034278 is an observational study that tracks outcomes without assigning an intervention. The registered 785 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Not applicable - no intervention is the first listed.
NCT03034278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03034278 about?
NCT03034278 is a clinical study titled "Self-reported Usage Patterns of Opioid Analgesic Medications After Surgery". The primary objective of this study is to better understand post-discharge utilization of prescribed opioid analgesic medications following surgery. A secondary objective of this study is to gain a better understanding of prevailing modes of storage for opioid medications.
What is the current status of trial NCT03034278?
This trial is currently completed. The enrollment target is 785 participants. The study started on 2017-02-03. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03034278?
The interventions under investigation include: Not applicable - no intervention (OTHER).
Who is sponsoring clinical trial NCT03034278?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06498128 · 785 participants
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
- NCT07276724 · 786 participants · Phase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- NCT07359846 · 786 participants · Phase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- NCT06118723 · 784 participants
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI